Meropenem Bradex

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as a sterile injectable powder for intravenous use. It treats serious bacterial infections in hospitalized patients, including intra‑abdominal, urinary, pulmonary, and central nervous system infections.

GNH USA supplies Meropenem Bradex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat severe bacterial infections across several organ systems. - Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure. - Complicated urinary tract infections: clears resistant Gram‑negative pathogens. - Hospital‑acquired pneumonia: provides effective coverage against multidrug‑resistant organisms. - Ventilator‑associated pneumonia: restores lung function by eliminating causative bacteria. - Severe sepsis and septic shock: rapidly reduces bacterial load to support hemodynamic recovery. - Bacterial meningitis: penetrates the cerebrospinal fluid to eradicate meningitic pathogens.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruptions. - Headache: transient and usually resolves. - Elevated liver enzymes: mild transaminase increase. - Injection‑site pain: discomfort at the infusion site.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe diarrhea requiring medical attention. - Anaphylaxis: acute hypersensitivity with respiratory or circulatory collapse. - Seizures: particularly in patients with renal impairment or high doses. - Renal toxicity: acute kidney injury in susceptible individuals. - Severe hypersensitivity reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Careful assessment and monitoring are required before and during therapy. - Renal impairment: adjust dose based on creatinine clearance. - Hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy: use only if potential benefit justifies risk to the fetus. - Hepatic dysfunction: monitor liver function tests periodically. - Concomitant nephrotoxic drugs: avoid or monitor renal function closely. - Store below 25°C: keep in original packaging, protect from moisture and light.

Meropenem may interact with several agents, influencing efficacy or toxicity.

Major Interactions (Avoid): - Valproic acid: reduces serum levels, risking seizure breakthrough. - Probenecid: decreases renal clearance, increasing meropenem exposure. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Aminoglycosides: additive nephrotoxicity; avoid concurrent high‑dose use. - Other carbapenems: antagonistic effect on bacterial killing.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and renal function. - NSAIDs: watch for increased risk of renal impairment. - Oral contraceptives: possible reduction in efficacy; advise alternative contraception.